SCHEMBL7304267

SCHEMBL7304267

CSCC(=O)C(CCc1ccccc1)NCC(CC(C)C)NC(=O)OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PSMB1 P20618 1/20 0.54
PSMB5 P28074 1/20 0.54
PSMB2 P49721 1/20 0.54
CTSL P07711 11/20 0.50
CTSB P07858 6/20 0.50
CTSK P43235 9/20 0.48
CTSS P25774 3/20 0.48
CA5A P35218 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7302069 0.92 PSMB1 (0.54) PSMB1PSMB5PSMB2CTSLCTSB
SCHEMBL7312660 0.92 PSMB1 (0.60) PSMB1PSMB5PSMB2CTSLCTSB
SCHEMBL7305711 0.90 CTSL (0.52) PSMB1PSMB5PSMB2CTSLCTSB
SCHEMBL7306865 0.90 PSMB1 (0.56) PSMB1PSMB5PSMB2CTSLCTSB
SCHEMBL7306546 0.88 PSMB1 (0.54) PSMB1PSMB5PSMB2CTSLCTSB
SCHEMBL7300595 0.87 PSMB1 (0.52) PSMB1PSMB5PSMB2CTSLCTSB
SCHEMBL7304336 0.85 PSMB1 (0.53) PSMB1PSMB5PSMB2CTSLCTSB
SCHEMBL7310742 0.84 CTSL (0.47) PSMB1PSMB5PSMB2CTSLCTSB
SCHEMBL7304537 0.84 CTSL (0.47) PSMB1PSMB5PSMB2CTSLCTSB
SCHEMBL7314150 0.84 CTSK (0.56) PSMB1PSMB5PSMB2CTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0525420-B1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors MITSUBISHI CHEM CORP (JP) 1999-05-12 EP disclosed
US-5639783-A POTENT PROTEASE INHIBITOR FOR TREATING MUSCULAR, NERVOUS SYSTEM DISEASES MITSUBISHI CHEMICAL CORPORATION (JP) 1997-06-17 US disclosed
EP-0525420-A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors Mitsubishi Chemical Corporation (JP) 1993-02-03 EP disclosed